Donald Castell to Anti-Ulcer Agents
This is a "connection" page, showing publications Donald Castell has written about Anti-Ulcer Agents.
Connection Strength
4.910
-
Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough. J Clin Gastroenterol. 2008 Jul; 42(6):676-9.
Score: 0.305
-
Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest. 2006 Aug; 130(2):386-91.
Score: 0.267
-
Review of immediate-release omeprazole for the treatment of gastric acid-related disorders. Expert Opin Pharmacother. 2005 Nov; 6(14):2501-10.
Score: 0.253
-
Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005 Jun 15; 21(12):1467-74.
Score: 0.247
-
Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers. Aliment Pharmacol Ther. 2002 Apr; 16(4):829-36.
Score: 0.198
-
Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol. 2002 Mar; 97(3):575-83.
Score: 0.197
-
Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther. 2001 Sep; 15(9):1351-6.
Score: 0.190
-
Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology. 2001 Jun; 120(7):1599-606.
Score: 0.187
-
Maximal acid reflux control for Barrett's oesophagus: feasible and effective. Aliment Pharmacol Ther. 2001 Apr; 15(4):519-24.
Score: 0.184
-
Proton pump inhibitors: better acid suppression when taken before a meal than without a meal. Aliment Pharmacol Ther. 2000 Oct; 14(10):1267-72.
Score: 0.178
-
Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole. Aliment Pharmacol Ther. 2000 Jun; 14(6):709-14.
Score: 0.174
-
Acid suppression therapy in Barrett's esophagus: the importance of pH monitoring. Curr Gastroenterol Rep. 2000 Jun; 2(3):173-4.
Score: 0.174
-
Importance of adequate acid suppression in the management of Barrett's esophagus. Gastroenterology. 1999 Dec; 117(6):1509-10.
Score: 0.168
-
A practical approach to heartburn. Hosp Pract (1995). 1999 Nov 15; 34(12):89-94, 97-8.
Score: 0.168
-
Post-prandial ranitidine is superior to post-prandial omeprazole in control of gastric acidity in healthy volunteers. Aliment Pharmacol Ther. 1999 Sep; 13(9):1211-4.
Score: 0.165
-
Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH. Aliment Pharmacol Ther. 1999 May; 13(5):675-8.
Score: 0.161
-
Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology. 1998 Dec; 115(6):1335-9.
Score: 0.157
-
Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol. 1998 May; 93(5):763-7.
Score: 0.151
-
Acid control and regression of Barrett's esophagus: is the glass half full or half empty? Am J Gastroenterol. 1997 Dec; 92(12):2329-30.
Score: 0.146
-
Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy. Am J Gastroenterol. 1997 Mar; 92(3):429-37.
Score: 0.139
-
Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol. 1996 Aug; 91(8):1527-31.
Score: 0.133
-
Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol. 1996 Aug; 91(8):1532-8.
Score: 0.133
-
Omeprazole works best when used properly. Eur J Gastroenterol Hepatol. 1996 May; 8(5):413-4.
Score: 0.131
-
Omeprazole for the treatment of posterior laryngitis. Am J Med. 1995 Dec; 99(6):694-5.
Score: 0.127
-
Intragastric acidity after switching from 5-day treatment with intravenous pantoprazole 40 mg/d to 5-day treatment with oral esomeprazole 40 mg/d or pantoprazole 40 mg/d: an open-label crossover study in healthy adult volunteers. Clin Ther. 2006 May; 28(5):725-33.
Score: 0.066
-
Intragastric acid suppression and pharmacokinetics of twice-daily esomeprazole: a randomized, three-way crossover study. Aliment Pharmacol Ther. 2004 Aug 15; 20(4):399-406.
Score: 0.058
-
Diagnosis of laryngopharyngeal reflux. Curr Opin Otolaryngol Head Neck Surg. 2004 Jun; 12(3):174-9.
Score: 0.057
-
The acidity index: a simple approach to the measurement of gastric acidity. Aliment Pharmacol Ther. 2004 Feb 15; 19(4):443-8.
Score: 0.056
-
Esomeprazole resolves chronic heartburn in patients without erosive oesophagitis. Aliment Pharmacol Ther. 2003 Nov 01; 18(9):875-82.
Score: 0.055
-
Nocturnal acid breakthrough in perspective: let's not throw out the baby with the bath water. Am J Gastroenterol. 2003 Mar; 98(3):517-8.
Score: 0.053
-
Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors. Aliment Pharmacol Ther. 2002 Mar; 16(3):473-7.
Score: 0.049
-
Approach to the patient with unexplained chest pain. Compr Ther. 1997 Apr; 23(4):249-53.
Score: 0.035
-
Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and to direct therapy. Am J Gastroenterol. 1996 Sep; 91(9):1715-8.
Score: 0.034
-
Excluding gastroesophageal reflux disease as the cause of chronic cough. J Clin Gastroenterol. 1996 Apr; 22(3):168-9.
Score: 0.033
-
Gastroesophageal reflux disease. Current strategies for patient management. Arch Fam Med. 1996 Apr; 5(4):221-7.
Score: 0.033
-
Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases. Am J Gastroenterol. 1995 Oct; 90(10):1874-7.
Score: 0.031
-
Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005 Jan; 100(1):190-200.
Score: 0.015